Skip to main content
SpringerLink
Log in

CNS research in the pharmaceutical industry

A personal view of how innovation could be promoted by clinical pharmacology

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Conway J (1993) Cardiovascular research in the pharmaceutical industry: a personal appeal for rationalizing development. Eur J Clin Pharmacol 45: 395–396

    Google Scholar 

  2. Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C (1983) Severe anxiety induced by FG 7142, a β-carboline ligand for benzodiazepine receptors. Lancet II: 98–99

    Google Scholar 

  3. Schachter M, Bédard P, Debono AG, Jenner P, Marsden CD, Price P, Parkes JD, Keenan J, Smith B, Rosenthaler J, Horowski R, Dorow R (1980) The role of D1 and D2 receptors. Nature 286: 157–159

    Google Scholar 

  4. Horowski R, Sastre-y-Hernandez M (1985) Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports. Curr Ther Res 38: 23–29

    Google Scholar 

  5. Meltzer HY (ed) (1987) Psychopharmacology, the third generation of progress. Raven Press, New York

    Google Scholar 

  6. Calne DB (ed) (1994) Neurodegenerative diseases. Saunders, Philadelphia

    Google Scholar 

  7. AMDP and CIPS (eds) (1990) Rating scales for psychiatry, Beltz, Weinheim

    Google Scholar 

  8. Dirnagel U, Villringer A, Einhäupl KM (eds) (1993) Optical imaging of brain function and metabolism. Adv Exp Med Biol 333, Plenum Press, New York

    Google Scholar 

  9. Mazière B, Mazière M (1990) Where have we got to with neuroreceptor mapping of the human brain? Eur J Nucl Med 16: 817–835

    Google Scholar 

  10. Paty DW, Li DKB, UBC MS-MRI Study Group, IFNB Multiple Sclerosis Study Group (1993) Interferon beta-1 b is effective in relapsing-remitting multiple sclerosis. II. MRS analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 662–667

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sigismundkorso 52, D-13465, Berlin, Germany

    R. Horowski

Authors
  1. R. Horowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horowski, R. CNS research in the pharmaceutical industry. Eur J Clin Pharmacol 47, 467–468 (1995). https://doi.org/10.1007/BF00196864

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00196864

Key words

Search

Navigation